People · Operator
Named in public records as an officer, director or promoter · active 2017–2017 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Respira Therapeutics, Inc. | — | Pharmaceuticals | Series A | $9.1M | $282.0M | 2017 |
David M. Blivin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David M. Blivin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert M. Curtis | 1 | 2 |
| Brian P. Birk | 1 | 2 |
| Matthew P. Franklin | 1 | 1 |
| Andrew M. Clark | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.